510(k) Report

510(k) · Cleared

Cleared

Vitoss Scaffold Foam Bone Graft Material

K032288510(k) TraditionalCleared Dec 19, 2003148-day reviewClass II21 CFR 888.3045

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Orthovita, Inc. · MQV Filler, Bone Void, Calcium Compound

Cleared on Dec 19, 2003 after a 148-day review. The FDA summary names its predicate without a number. 123 later devices descend from it.

Decided
Dec 19, 2003
Review
148 days
Class
Class II
Product code
MQV
Recalls
None
Predicates
0

123 later devices descend from it, 17 citing it directly.

Descendants, by year cleared 2005: 2 descendants cleared2022: 7 descendants cleared2007: 5 descendants cleared2016: 4 descendants cleared2006: 4 descendants cleared2009: 7 descendants cleared2008: 7 descendants cleared2015: 6 descendants cleared2017: 7 descendants cleared2023: 8 descendants cleared2020: 7 descendants cleared2010: 6 descendants cleared2014: 10 descendants cleared2024: 12 descendants cleared2026: 2 descendants cleared2019: 4 descendants cleared2021: 3 descendants cleared2011: 6 descendants cleared2018: 7 descendants cleared2012: 2 descendants cleared2013: 4 descendants cleared2025: 3 descendants cleared200020052010201520202025
  1. This deviceK032288 Vitoss Scaffold Foam Bone Graft MaterialOrthovita, Inc. · 2003
  2. Descendant · cites it directly · 59 of its ownK051386 Mastergraft Putty Bone Void FillerMedtronic Vascular · 2005
  3. Descendant · cites it directly · 51 of its ownK072184 Vitoss Bioactive Foam Bone Graft SubstituteOrthovita, Inc. · 2007
  4. Descendant · 2 generations on · 50 of its ownK081439 Vitoss Bioactive Foam Pack Bone Graft SubstituteOrthovita, Inc. · 2008
  5. Descendant · cites it directly · 47 of its ownK083033 Vitoss Bone Graft Substitute, Bone Graft Substitute Filled Canister…Orthovita, Inc. · 2008
  6. Descendant · cites it directly · 47 of its ownK071813 Mastergraft PuttyMedtronic Sofamor Danek · 2007

Showing 5 of 123 descendants. See all descendants

Descendants cleared per year

2005: 22006: 42007: 52008: 72009: 72010: 62011: 62012: 22013: 42014: 102015: 62016: 42017: 72018: 72019: 42020: 72021: 32022: 72023: 82024: 122025: 32026: 2
2005high 12 (2024) · low 2 (2005)2026

Most influential descendants

Showing 5 of 123 · See all
  • K051386Mastergraft Putty Bone Void FillerMedtronic Vascular · 2005 · cites it directly59descendants
  • K072184Vitoss Bioactive Foam Bone Graft SubstituteOrthovita, Inc. · 2007 · cites it directly51descendants
  • K081439Vitoss Bioactive Foam Pack Bone Graft SubstituteOrthovita, Inc. · 2008 · 2 generations on50descendants
  • K083033Vitoss Bone Graft Substitute, Bone Graft Substitute Filled Canister, Foam & Bioactive…Orthovita, Inc. · 2008 · cites it directly47descendants
  • K071813Mastergraft PuttyMedtronic Sofamor Danek · 2007 · cites it directly47descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K032288Vitoss Scaffold Foam Bone Graft MaterialOrthovita, Inc.2003—
+1K051386Mastergraft Putty Bone Void FillerMedtronic Vascular2005—
+1K072184Vitoss Bioactive Foam Bone Graft SubstituteOrthovita, Inc.2007—
+2K081439Vitoss Bioactive Foam Pack Bone Graft SubstituteOrthovita, Inc.2008—
+1K083033Vitoss Bone Graft Substitute, Bone Graft Substitute Filled Canister, Foam &…Orthovita, Inc.2008—
+1K071813Mastergraft PuttyMedtronic Sofamor Danek2007—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200520
200640
200750
200870
200970
201060
201160
201220
201340
2014100
201560
201640
201770
201870
201940
202070
202130
202270
202380
2024120
202530
202620
FIG. 1 — Lineage of K032288, 2003–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Vitoss Scaffold Synthetic Cancellous Bone Void Filler
Named without a submission number
—
*—Healos Bone Graft Material
Named without a submission number
—

What descends from it? (123)

See all 123

17 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K051386Mastergraft Putty Bone Void FillerMedtronic Vascular200559
K072184Vitoss Bioactive Foam Bone Graft SubstituteOrthovita, Inc.200751
K083033Vitoss Bone Graft Substitute, Bone Graft Substitute Filled Canister, Foam & Bioactive…Orthovita, Inc.200847
K071813Mastergraft PuttyMedtronic Sofamor Danek200747
K063124Integra Mozaik Bone Regeneration Matrix - StripsIntegra Lifesciences Corp.200740
K052812Ossimend (TM) Bone Graft MaterialCollagen Matrix, Inc.200640
K050789Formagraft Collagen Bone Graft MatrixR and D Medical, LLC200511
K081558Pioneer Surgical Technology Nanoss BVF-E, Models 5, 10, 20CCPioneer Surgical Technology200810
K091031Pioneer Surgical Nanoss BVF-EPioneer Surgical Technology20097
K142276MCS Bone GraftBiostructures, LLC20153

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K051386 (Medtronic Vascular, 2005) has gone furthest, with 59 descendants of its own.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

Vitoss Scaffold Foam Bone Graft Material is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Vitoss Scaffold Foam is indicated for use in the treatment of surgically created osseous defects or osseous defects created from traumatic injury to the bone. Vitoss Scaffold Foam should not be used to treat large defects that in the surgeon's opinion would fail to heal spontaneously. Vitoss…

Read the full statement (123 words)

Vitoss Scaffold Foam Bone Graft Material is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Vitoss Scaffold Foam is indicated for use in the treatment of surgically created osseous defects or osseous defects created from traumatic injury to the bone. Vitoss Scaffold Foam should not be used to treat large defects that in the surgeon's opinion would fail to heal spontaneously.

Vitoss Scaffold Foam Bone Graft Material is intended to be used for filling bony voids or gaps of the skeletal system (i.e., the extremities, spine and pelvis). Following placement in the bony void or gap, the scaffold resorbs and is replaced with bone during the healing process.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K032288: Vitoss Scaffold Foam Bone Graft Material.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K032288

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026